Overview
Filings
39 filings to the SEC since October 2021: 39 other. The latest 20:
- Jun 8, 2026QUALIF EDGAR
- Jun 4, 2026CORRESP EDGAR
- May 21, 2026UPLOAD EDGAR
- May 15, 20261-A EDGAR
- May 19, 2025253G2 EDGAR
- Mar 19, 2025QUALIF EDGAR
- Mar 18, 2025CORRESP EDGAR
- Mar 17, 2025CORRESP EDGAR
- Mar 17, 20251-A POS EDGAR
- Mar 17, 2025UPLOAD EDGAR
- Mar 6, 20251-A POS EDGAR
- Jan 22, 20251-U EDGAR
- Sep 19, 2024253G2 EDGAR
- Sep 17, 2024QUALIF EDGAR
- Sep 16, 2024CORRESP EDGAR
- Sep 16, 2024CORRESP EDGAR
- Sep 6, 2024CORRESP EDGAR
- Sep 6, 20241-A POS EDGAR
- Sep 5, 2024UPLOAD EDGAR
- Aug 19, 20241-A POS EDGAR
The 39 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
SEC filer profile
How CBD Life Sciences Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARCBD Life Sciences Inc.1
- CIK0001776073
- Employer ID (EIN)20-51185321
- Incorporated inNevada1
- Fiscal year endsDecember 311
- Industry code (SIC)2833 Medicinal Chemicals & Botanical Products1
- SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance1
- Business address10953 N. Frank Lloyd Wright Blvd., Unit 108, Scottsdale, AZ1
- Phone480-209-17201
- On EDGAR sinceMay 22, 20191
- Filings82 in all: CORRESP (21), UPLOAD (15), 1-A/A (11), 1-A POS (10), QUALIF (9), 253G2 (5), 1-A (4), 1-U (2)1
All 11 form types
1-Z (2), 253G1 (2), 1-K (1)
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2